Patents by Inventor Yong Ji

Yong Ji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12109296
    Abstract: The present disclosure relates to a peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, 3, or 4, a pharmaceutical composition for preventing or treating skin disease including the peptide, a cosmetic composition for skin condition improvement including the peptide, a food composition for skin condition improvement including the peptide, a method of preventing or treating skin disease using the peptide, and a use of the peptide in preventing or treating skin disease or improving skin condition.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: October 8, 2024
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung Ji Lee
  • Patent number: 12091457
    Abstract: The present invention relates to an antibody or an antigen-binding fragment thereof specifically binding to CD66c which is expressed in myeloid-derived suppressor cell (MDSC) and a use thereof, and specifically to an antibody or an antigen-binding fragment thereof specifically binding to CD66c, a pharmaceutical composition or a diagnosing composition including the same. The anti-CD66c antibody of the present invention can be used usefully for the treatment of various diseases by targeting MDSC which can induce the immunosuppression.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: September 17, 2024
    Assignee: KUMHO HT, INC.
    Inventors: Soseul Kim, Jeong Won Hong, Gil Yong Ji, Sangsoon Yoon, Hyung-Geun Song
  • Publication number: 20240299560
    Abstract: The present invention relates to: a deoxycholic acid-peptide conjugate having anti-obesity activity by inhibiting lipid production and promoting lipolysis; and a use for preventing, ameliorating or treating obesity comprising the conjugate as an active ingredient.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 12, 2024
    Applicant: CAREGEN CO, LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Seon Soo KIM
  • Publication number: 20240287188
    Abstract: The present invention relates to an anti-ICAM-1 antibody or an antigen-binding fragment thereof that specifically binds to ICAM-1, and the use thereof.
    Type: Application
    Filed: December 31, 2019
    Publication date: August 29, 2024
    Inventors: Yoo Ri MOON, Gil Yong JI, Sangsoon YOON, Jung Sik KIM
  • Publication number: 20240287133
    Abstract: The present invention relates to a peptide of a novel sequence, having the activities of preventing hair loss and promoting hair growth, the peptide having the activity of promoting or inducing the proliferation or activation of cells related to hair formation, and thus a composition comprising the peptide can be effectively used for preventing hair loss or promoting hair growth.
    Type: Application
    Filed: September 28, 2022
    Publication date: August 29, 2024
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE, Min Woong KIM, Hana GIL
  • Publication number: 20240285780
    Abstract: The present invention relates to a trolox-peptide conjugate which exhibits activity that relieves muscle contraction and increases the extracellular matrix, and which can be used as an active ingredient of a drug, a quasi-drug or a cosmetic product for muscle relaxation, neuromuscular disorder prevention or treatment, or the improvement of skin conditions including skin wrinkles.
    Type: Application
    Filed: June 11, 2021
    Publication date: August 29, 2024
    Applicant: CAREGEN CO, LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE, Young Min LEE, Han A KANG
  • Patent number: 12064502
    Abstract: The present disclosure relates to a peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, 3, or 4, a pharmaceutical composition for preventing or treating skin disease including the peptide, a cosmetic composition for skin condition improvement including the peptide, a food composition for skin condition improvement including the peptide, a method of preventing or treating skin disease using the peptide, and a use of the peptide in preventing or treating skin disease or improving skin condition.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: August 20, 2024
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung Ji Lee
  • Publication number: 20240193701
    Abstract: A communication system retrieves profile data corresponding to a user profile of a second user, identifies a status message in the profile data, display, via a user interface of the instant messenger application, the status message; in response to receiving, via the user interface, a user input associated with the status message: query, based on the status message, a database to identify one or more items, and display, via the user interface of the instant messenger application, item data corresponding to the one or more items, receive, via the user interface, a user input associated with the one or more items, instantiate a transaction authentication of the one or more items by causing transmission of transaction information data associated with the first user, and cause, based on the transaction authentication of the one or more items, delivery of the one or more items to an account of the second user.
    Type: Application
    Filed: December 7, 2023
    Publication date: June 13, 2024
    Inventors: Sul Gi Kim, Ji Hwi Park, Yun Jin Kim, Nam Hee Ko, Hye Seon Kim, Bo Young Jang, Sun Je Bang, Ji On Chu, Seung Yong Ji, Jae Ick Hwang, Eun Ho Son, Sang Min Seo, Jeong Ryeol Choi, Hye Mi Lee, Shin Young Lee, Seung Uk Jeong
  • Patent number: 12005123
    Abstract: A compound comprising a structure in which isotretinoin is linked to a peptide via a covalent bond and an antibiotic, anti-inflammatory, or anti-oxidative pharmaceutical or cosmetic composition comprising the same. A compound having a structure in which isotretinoin is linked to a peptide via a covalent bond according to the present invention exhibits excellent physiological activity such as antibiotic, anti-inflammatory, or anti-oxidative actions, as well as having outstanding properties, such as solubility in water, etc., and thus can find useful applications in various fields including medicines, cosmetics, etc.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: June 11, 2024
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim
  • Publication number: 20240163234
    Abstract: Provided is a method of operating a terminal. The method includes determining a profile item applicable to the profile view for the account based on an input received by the terminal and a coordinate indicating a position where the profile item is provided on the profile view. The method includes displaying the profile item on a screen of the terminal based on the determined profile item and the determined coordinate. The method includes receiving an input related to the profile item, and displaying a visual effect corresponding to the input on the screen.
    Type: Application
    Filed: November 8, 2023
    Publication date: May 16, 2024
    Inventors: Sul Gi KIM, Ji Hwi PARK, Yun Jin KIM, Nam Hee KO, Hye Seon KIM, Bo Young JANG, Seung Yong JI, Jae Ick HWANG, Sun Je BANG, Ji On CHU, Hye Mi LEE, Shin Young LEE, Seung Uk JEONG, Eun Ho SON, Sang Min SEO, Jeong Ryeol CHOI
  • Publication number: 20240092829
    Abstract: The present application relates to a peptide having protective activity against cell damage caused by particulate matter, and to uses for the peptide.
    Type: Application
    Filed: November 26, 2020
    Publication date: March 21, 2024
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE, Han A KANG, Bo Byeol HWANG
  • Patent number: 11905331
    Abstract: The present invention relates to an anti-CD40 antibody binding specifically to CD40 and use thereof and, particularly, provides an anti-CD40 antibody or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same antibody or fragment as an effective ingredient for prevention and/or treatment of cancer, cancer metastasis, infection, and/or immune deficiency diseases.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: February 20, 2024
    Assignee: KUMHO HT, INC.
    Inventors: Gil Yong Ji, Kwon Pyo Hong, Eui Sup Lee, Yoo Ri Moon, Sangsoon Yoon
  • Publication number: 20240051993
    Abstract: The present invention relates to a peptide that specifically recognizes a protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a portion thereof; a composition for preventing or treating SARS-CoV-2 infection, comprising the peptide; and a composition for detecting SARS-CoV-2, comprising the peptide.
    Type: Application
    Filed: July 15, 2021
    Publication date: February 15, 2024
    Applicant: CAREGEN CO, LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE, Young Min LEE, Han A KANG, Min Kyeong JEONG
  • Patent number: 11880459
    Abstract: Various embodiments include a mobile storage device control system. The system may include an independently operating scanning apparatus configured to: detect insertion of a mobile storage device, scan the mobile storage device to determine whether the mobile storage device poses a security threat, perform a specific operation on the mobile storage device so the specific operation is recorded in a file system log of the mobile storage device, and the record of the specific operation is used to mark whether the mobile storage device has been modified after being scanned. The system may include a control apparatus configured to: detect insertion of the mobile storage device, check whether the last record in the file system log in the mobile storage device is the record of the specific operation, if so, permit a user to access the mobile storage device and otherwise prohibit the user from accessing the mobile storage device.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: January 23, 2024
    Assignee: SIEMENS AKTIENGESELLSCHAFT
    Inventors: Zhe Wang, Yong Ji Gao
  • Publication number: 20240002439
    Abstract: The present application relates to a peptide having protective activity against cell damage caused by particulate matter, and to uses for the peptide.
    Type: Application
    Filed: November 26, 2020
    Publication date: January 4, 2024
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE, Han A KANG, Bo Byeol HWANG
  • Patent number: 11859016
    Abstract: Provided are a peptide with a cytoprotective effect against environmental pollutants and a use thereof. The peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, or 3 directly binds to 2,3,7,8-tetrachlorodibenzo-p-dioxin (hereinafter, referred to as TCDD), known as being the most toxic among the class of dioxins, to prevent dermal penetration and the activation mechanism of AhR by TCDD and polycyclic aromatic hydrocarbons contained in fine dust. Such a direct cytoprotective effect against environmental pollutants is distinguished from preexisting methods that are configured to indirectly block opportunities to contact these materials or to reduce toxicity through barrier reinforcement.
    Type: Grant
    Filed: January 24, 2023
    Date of Patent: January 2, 2024
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung-ji Lee
  • Publication number: 20230321181
    Abstract: The present invention related to a composition for the prevention, improvement or treatment of allergic diseases or itching.
    Type: Application
    Filed: June 11, 2021
    Publication date: October 12, 2023
    Applicant: CAREGEN CO, LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Seon Soo KIM
  • Publication number: 20230285264
    Abstract: The present disclosure relates to a peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, 3, or 4, a pharmaceutical composition for preventing or treating skin disease including the peptide, a cosmetic composition for skin condition improvement including the peptide, a food composition for skin condition improvement including the peptide, a method of preventing or treating skin disease using the peptide, and a use of the peptide in preventing or treating skin disease or improving skin condition.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 14, 2023
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE
  • Publication number: 20230285263
    Abstract: The present disclosure relates to a peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, 3, or 4, a pharmaceutical composition for preventing or treating skin disease including the peptide, a cosmetic composition for skin condition improvement including the peptide, a food composition for skin condition improvement including the peptide, a method of preventing or treating skin disease using the peptide, and a use of the peptide in preventing or treating skin disease or improving skin condition.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 14, 2023
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung Ji LEE
  • Publication number: 20230227501
    Abstract: Provided are a peptide with a cytoprotective effect against environmental pollutants and a use thereof. The peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, or 3 directly binds to 2,3,7,8-tetrachlorodibenzo-p-dioxin (hereinafter, referred to as TCDD), known as being the most toxic among the class of dioxins, to prevent dermal penetration and the activation mechanism of AhR by TCDD and polycyclic aromatic hydrocarbons contained in fine dust. Such a direct cytoprotective effect against environmental pollutants is distinguished from preexisting methods that are configured to indirectly block opportunities to contact these materials or to reduce toxicity through barrier reinforcement.
    Type: Application
    Filed: January 24, 2023
    Publication date: July 20, 2023
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung-ji LEE